<!DOCTYPE html>
<html lang="en" dir="ltr">
  <head>
    <meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0">
      <title>
        Tb Burden
      </title>
      <meta property="og:title" content="Tb Burden">
    <meta charset="utf-8">
    <meta property="og:type" content="article">

      <meta property="og:description" content="Short description of your project">
      <meta property="description" content="Short description of your project">
    <link rel="stylesheet" href="styles.css">
  </head>
  <body>
    <div id="idyll-mount"><div class="idyll-root" data-reactroot=""><div class="article-header"><h1 class="hed">India&#x27;s Tuberculosis Burden</h1><h2 class="dek">A breakdown of patients in India vs world</h2><div class="byline">By: <a href="https://bkamapantula.github.io">Bhanu</a></div></div><div class="aside-container"><div class="aside"><div><div style="height:100%;width:100%;pointer-events:none;touch-action:none;position:relative" class="VictoryContainer"><svg width="400" height="400" role="img" aria-labelledby="victory-container-1-title victory-container-1-desc" viewBox="0 0 400 400" style="pointer-events:all;width:100%;height:100%"><g><path d="M9.184850993605149e-15,-150A150,150,0,0,1,112.27661222566518,-99.46839873611928L0,0Z" role="presentation" style="event-key:0;x-name:India (2.8m);fill:#880000;padding:10px;stroke:transparent;stroke-width:1" transform="translate(200, 200)" shape-rendering="auto"></path><path d="M112.27661222566518,-99.46839873611928A150,150,0,1,1,-112.27661222566518,99.46839873611928L0,0Z" role="presentation" style="event-key:1px;x-name:Global;fill:#008ABE;padding:10px;stroke:transparent;stroke-width:1" transform="translate(200, 200)" shape-rendering="auto"></path><path d="M-112.27661222566518,99.46839873611928A150,150,0,0,1,-2.7554552980815446e-14,-150L0,0Z" role="presentation" style="event-key:2px;x-name:Other;fill:#888;padding:10px;stroke:transparent;stroke-width:1" transform="translate(200, 200)" shape-rendering="auto"></path><text dx="0" dy="-2.0300000000000002" x="270" y="45"><tspan x="270" dx="0" style="fill:#252525;font-size:14px;font-family:&#x27;Gill Sans&#x27;, &#x27;Gill Sans MT&#x27;, &#x27;Ser­avek&#x27;, &#x27;Trebuchet MS&#x27;, sans-serif;stroke:transparent;padding:20px;letter-spacing:normal" text-anchor="middle">India (2.8m)</tspan></text><text dx="0" dy="11.969999999999999" x="313" y="327"><tspan x="313" dx="0" style="fill:#252525;font-size:14px;font-family:&#x27;Gill Sans&#x27;, &#x27;Gill Sans MT&#x27;, &#x27;Ser­avek&#x27;, &#x27;Trebuchet MS&#x27;, sans-serif;stroke:transparent;padding:20px;letter-spacing:normal" text-anchor="middle">Global</tspan></text><text dx="0" dy="4.97" x="45" y="130"><tspan x="45" dx="0" style="fill:#252525;font-size:14px;font-family:&#x27;Gill Sans&#x27;, &#x27;Gill Sans MT&#x27;, &#x27;Ser­avek&#x27;, &#x27;Trebuchet MS&#x27;, sans-serif;stroke:transparent;padding:20px;letter-spacing:normal" text-anchor="end">Other</tspan></text></g></svg><div style="z-index:99;position:absolute;top:0;left:0;width:100%;height:100%"><svg width="400" height="400" viewBox="0 0 400 400" style="overflow:visible;width:100%;height:100%"></svg></div></div></div></div></div><p>India is a leading contributor to the global Tuberculosis burden. India shares <code><!-- -->27%</code> of the global burden.</p><div class="ReactTable table "><div class="rt-table"><div class="rt-thead -header" style="min-width:400px"><div class="rt-tr"><div class=" rt-resizable-header -cursor-pointer rt-th" style="flex:100 0 auto;width:100px"><div class="rt-resizable-header-content">Estimates of TB Burden (2015)</div><div class="rt-resizer"></div></div><div class=" rt-resizable-header -cursor-pointer rt-th" style="flex:100 0 auto;width:100px"><div class="rt-resizable-header-content">Global</div><div class="rt-resizer"></div></div><div class=" rt-resizable-header -cursor-pointer rt-th" style="flex:100 0 auto;width:100px"><div class="rt-resizable-header-content">India</div><div class="rt-resizer"></div></div><div class=" rt-resizable-header -cursor-pointer rt-th" style="flex:100 0 auto;width:100px"><div class="rt-resizable-header-content">% of Global</div><div class="rt-resizer"></div></div></div></div><div class="rt-tbody" style="min-width:400px"><div class="rt-tr-group"><div class="rt-tr -odd"><div class="rt-td" style="flex:100 0 auto;width:100px">Incidence TB cases</div><div class="rt-td" style="flex:100 0 auto;width:100px">10.4m</div><div class="rt-td" style="flex:100 0 auto;width:100px">2.8m</div><div class="rt-td" style="flex:100 0 auto;width:100px">27%</div></div></div><div class="rt-tr-group"><div class="rt-tr -even"><div class="rt-td" style="flex:100 0 auto;width:100px">Mortality of TB</div><div class="rt-td" style="flex:100 0 auto;width:100px">1.4m</div><div class="rt-td" style="flex:100 0 auto;width:100px">0.48m</div><div class="rt-td" style="flex:100 0 auto;width:100px">34%</div></div></div><div class="rt-tr-group"><div class="rt-tr -odd"><div class="rt-td" style="flex:100 0 auto;width:100px">Incidence HIV TB</div><div class="rt-td" style="flex:100 0 auto;width:100px">1.17m</div><div class="rt-td" style="flex:100 0 auto;width:100px">0.11m</div><div class="rt-td" style="flex:100 0 auto;width:100px">9%</div></div></div><div class="rt-tr-group"><div class="rt-tr -even"><div class="rt-td" style="flex:100 0 auto;width:100px">Mortality of HIV-TB</div><div class="rt-td" style="flex:100 0 auto;width:100px">0.39m</div><div class="rt-td" style="flex:100 0 auto;width:100px">37,000</div><div class="rt-td" style="flex:100 0 auto;width:100px">9%</div></div></div><div class="rt-tr-group"><div class="rt-tr -odd"><div class="rt-td" style="flex:100 0 auto;width:100px">MDR-TB</div><div class="rt-td" style="flex:100 0 auto;width:100px">0.48m</div><div class="rt-td" style="flex:100 0 auto;width:100px">0.13m</div><div class="rt-td" style="flex:100 0 auto;width:100px">27%</div></div></div></div></div><div class="-loading"><div class="-loading-inner">Loading...</div></div></div><em>Global and India figures are in millions except for Mortality of HIV-TB</em><h3>Only <!-- -->1<!-- --> in <!-- -->1<!-- -->9<!-- -->7<!-- --> patients have access to Bedaquiline</h3><p>Out of <code><!-- -->1,30,000</code><code>MDR-TB</code> (multidrug-resistant Tuberculosis) patients, only <code><!-- -->660</code> patients are on Bedaquiline.</p><div class="aside-container"><div class="aside"><div><div style="height:100%;width:100%;pointer-events:none;touch-action:none;position:relative" class="VictoryContainer"><svg width="400" height="400" role="img" aria-labelledby="victory-container-2-title victory-container-2-desc" viewBox="0 0 400 400" style="pointer-events:all;width:100%;height:100%"><g><path d="M9.184850993605149e-15,-150A150,150,0,1,1,-4.75991826473,-149.92445823851787L0,0Z" role="presentation" style="event-key:0;x-name:MDR-TB patients in India (130000);fill:#888;padding:10px;stroke:transparent;stroke-width:1" transform="translate(200, 200)" shape-rendering="auto"></path><path d="M-4.75991826473,-149.92445823851787A150,150,0,0,1,-2.7554552980815446e-14,-150L0,0Z" role="presentation" style="event-key:1px;x-name:Patients on Bedaquiline (660);fill:#880000;padding:10px;stroke:transparent;stroke-width:1" transform="translate(200, 200)" shape-rendering="auto"></path><text dx="0" dy="11.969999999999999" x="203" y="370"><tspan x="203" dx="0" style="fill:#252525;font-size:14px;font-family:&#x27;Gill Sans&#x27;, &#x27;Gill Sans MT&#x27;, &#x27;Ser­avek&#x27;, &#x27;Trebuchet MS&#x27;, sans-serif;stroke:transparent;padding:20px;letter-spacing:normal" text-anchor="middle">MDR-TB patients in India (130000)</tspan></text><text dx="0" dy="-2.0300000000000002" x="197" y="30"><tspan x="197" dx="0" style="fill:#252525;font-size:14px;font-family:&#x27;Gill Sans&#x27;, &#x27;Gill Sans MT&#x27;, &#x27;Ser­avek&#x27;, &#x27;Trebuchet MS&#x27;, sans-serif;stroke:transparent;padding:20px;letter-spacing:normal" text-anchor="middle">Patients on Bedaquiline (660)</tspan></text></g></svg><div style="z-index:99;position:absolute;top:0;left:0;width:100%;height:100%"><svg width="400" height="400" viewBox="0 0 400 400" style="overflow:visible;width:100%;height:100%"></svg></div></div></div></div></div><p>Bedaquiline is a drug used to treat TB patients that are multidrug resistant. The government relies on a USAID donation (United States Agency for International Development) via an American pharmaceutical company Janssen. This is however limited to patients living in a 5 kilometer radius of <a href="#sources"><!-- -->6 designated hospitals</a>.</p><h3>Sources</h3><ol><li><a href="https://twitter.com/VidyaKrishnan/status/918160082591997954">@VidyaKrishnan</a></li><li>Tall claims on killing tuberculosis, <a href="http://www.thehindu.com/sci-tech/health/tall-claims-on-killing-tuberculosis/article19700240.ece"><!-- -->TheHindu</a></li></ol></div></div>
    <script src="index.js"></script>
  </body>
</html>
